{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:48Z","timestamp":1760060088701,"version":"build-2065373602"},"reference-count":109,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clindermatol.2021.05.023","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T08:20:37Z","timestamp":1621326037000},"page":"879-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Skin diseases in Asian individuals that you do not want to miss: A selection of unique or relatively more common conditions in Asian populations"],"prefix":"10.1016","volume":"39","author":[{"given":"Janice","family":"Tiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Al Janahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kee Yang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je-Ho","family":"Mun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.05.023_bib0001","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1067\/mjd.2003.274","article-title":"Ethnic skin disorders overview","volume":"48","author":"Halder","year":"2003","journal-title":"J Amer Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijd.14153","article-title":"Characteristics and management of Asian skin","volume":"58","author":"Chan","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0003","unstructured":"Worldometer website. Asia population. Available at: https:\/\/www.worldometers.info\/world-population\/asia-population\/. Accessed December 15, 2019."},{"year":"2010","series-title":"Modified race data 2010","key":"10.1016\/j.clindermatol.2021.05.023_bib0004"},{"year":"2001","series-title":"Profiles of general demographic characteristics: 2000 census of population and housing","key":"10.1016\/j.clindermatol.2021.05.023_bib0005"},{"year":"2008","series-title":"Cohn D. U.S. population projections: 2005-2050","author":"Passel","key":"10.1016\/j.clindermatol.2021.05.023_bib0006"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0007","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/0378-6323.29334","article-title":"Prurigo pigmentosa: an underdiagnosed disease?","volume":"72","author":"Boer","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jdcr.2014.12.005","article-title":"Erythematous papules evolving into reticulated hyperpigmentation on the trunk: a case of prurigo pigmentosa","volume":"1","author":"Corley","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1346-8138.1978.tb01049.x","article-title":"Prurigo pigmentosa\u2013clinical observations of our 14 cases","volume":"5","author":"Nagashima","year":"1978","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jamadermatol.2016.4921","article-title":"Prurigo pigmentosa in white monozygotic twins","volume":"153","author":"Houriet","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0011","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/jdv.13659","article-title":"Prurigo pigmentosa: a clinical and histopathological study of nine Chinese cases","volume":"30","author":"Zeng","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdcr.2017.07.027","article-title":"Prurigo pigmentosa: case series and differentiation from confluent and reticulated papillomatosis","volume":"4","author":"Shevchenko","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0013","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/cup.12763","article-title":"Prurigo pigmentosa: an under-recognized inflammatory dermatosis characterized by an evolution of distinctive clinicopathological features","volume":"43","author":"Satter","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0014","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1346-8138.2012.01640.x","article-title":"Prurigo pigmentosa: clinicopathological study and analysis of 50 cases in Korea","volume":"39","author":"Kim","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/pde.12275","article-title":"Prurigo pigmentosa after a strict ketogenic diet","volume":"32","author":"Michaels","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0016","first-page":"42","article-title":"Skin eruption induced by dieting\u2013an underdiagnosed skin disease in Malaysia","volume":"14","author":"Goh","year":"2019","journal-title":"Malays Fam Physician"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0017","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jdcr.2019.03.011","article-title":"Prurigo pigmentosa following ketogenic diet and bariatric surgery: a growing association","volume":"5","author":"Alshaya","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0018","first-page":"e10","article-title":"Prurigo pigmentosa induced by ketosis: resolution through dietary modification","volume":"103","author":"Hartman","year":"2019","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0019","first-page":"114","article-title":"Treatment of prurigo pigmentosa with diet modification: a medical case study","volume":"77","author":"Maco","year":"2018","journal-title":"Hawaii J Med Public Health"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/1346-8138.13307","article-title":"Pustular prurigo pigmentosa treated with doxycycline","volume":"43","author":"Kim","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0021","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/dth.12216","article-title":"The efficacy of minocycline in inflammatory dermatoses: a case of prurigo pigmentosa of prepubescent onset in Western world","volume":"28","author":"Gironi","year":"2015","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0022","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1468-3083.2005.01179.x","article-title":"Vesiculous prurigo pigmentosa in a 13-year-old girl: good response to isotretinoin","volume":"19","author":"Requena Caballero","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0023","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1346-8138.2011.01368.x","article-title":"Prurigo pigmentosa treated with Jessner's peel and irradiation with an 830-nm light-emitting diode","volume":"39","author":"Choi","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0024","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1590\/abd1806-4841.20175355","article-title":"Solitary ulcerated plaque on the face\u2013an unusual presentation of cutaneous plasmacytosis?","volume":"92","author":"Ant\u00f3nio","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0025","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/pde.12449","article-title":"Isolated benign primary cutaneous plasmacytosis in a child","volume":"31","author":"On","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0026","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000246848","article-title":"Primary cutaneous plasmacytosis: report of three cases and review of the literature","volume":"189","author":"Uhara","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0027","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5021\/ad.2014.26.1.121","article-title":"Congenital form of isolated benign primary cutaneous plasmacytosis in a child","volume":"26","author":"Song","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0028","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1346-8138.2010.01111.x","article-title":"Case of isolated benign primary cutaneous plasmacytosis in a child","volume":"38","author":"Ahn","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archdermatol.2008.596","article-title":"Isolated benign primary cutaneous plasmacytosis in children: two illustrative cases","volume":"145","author":"Gilliam","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1468-3083.2002.00411.x","article-title":"Primary cutaneous plasmacytosis in a child. Is this a new entity?","volume":"16","author":"Arico","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0031","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4103\/ijdvl.IJDVL_874_16","article-title":"Cutaneous plasmacytosis: a rare entity with unique presentation","volume":"83","author":"Dhar","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0032","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.4081\/dr.2011.e39","article-title":"Cutaneous plasmacytosis: a case report and review of pulmonary findings","volume":"3","author":"Chantachaeng","year":"2011","journal-title":"Dermatol Rep"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0033","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1111\/ijd.12370","article-title":"Isolated benign primary cutaneous plasmacytosis","volume":"53","author":"Shiba","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0034","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/00015550510027810","article-title":"Primary cutaneous plasmacytosis successfully treated with topical photodynamic therapy","volume":"85","author":"Tzung","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0019-5154.177768","article-title":"Primary cutaneous plasmacytosis: masquerading as hidradenitis suppurativa","volume":"61","author":"Goyal","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0036","doi-asserted-by":"crossref","first-page":"759","DOI":"10.5021\/ad.2015.27.6.759","article-title":"Cutaneous and systemic plasmacytosis associated with renal amyloidosis","volume":"27","author":"Lee","year":"2015","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0037","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000372-199706000-00016","article-title":"Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia","volume":"19","author":"Nitta","year":"1997","journal-title":"Am J Dermatopath"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0038","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjd.13296","article-title":"IgG4-related skin disease","volume":"171","author":"Tokura","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0039","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/ijd.12694","article-title":"Cutaneous plasmacytosis: a clinicopathologic study of 12 cases in Taiwan revealing heterogeneous underlying causes","volume":"54","author":"Lu","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0040","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1159\/000456073","article-title":"Characterization of cutaneous plasmacytosis at different disease stages","volume":"232","author":"Hsiao","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0041","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clml.2011.07.004","article-title":"Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis","volume":"11","author":"Haque","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0042","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2012.11.031","article-title":"Cutaneous plasmacytosis: report of 6 cases with or without systemic involvement","volume":"68","author":"Honda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0043","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1111\/1346-8138.13638","article-title":"Case of lipodystrophia centrifugalis abdominalis infantilis successfully treated with topical application of tacrolimus","volume":"44","author":"Hashizume","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0044","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1525-1470.2011.01584.x","article-title":"Lipodystrophia centrifugalis abdominalis infantilis: statistical analysis of 168 cases","volume":"29","author":"Imamura","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1525-1470.2011.01412.x","article-title":"Lipodystrophia centrifugalis abdominalis infantilis: report of four cases","volume":"29","author":"Wu","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0046","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1468-3083.2007.02102.x","article-title":"Centrifugal lipodystrophy mimicking \u2018lipodystrophia centrifugalis abdominalis infantilis\u2019 in a Caucasian adult","volume":"21","author":"Avil\u00e9s","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0047","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000246412","article-title":"Localized lipoatrophia with persistent circulating autoantibodies and partial immunoglobulin A deficiency in a child","volume":"192","author":"Tr\u00e9meau-Martinage","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0048","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archderm.1971.04000210065012","article-title":"Lipodystrophia centrifugalis abdominalis infantilis","volume":"104","author":"Imamura","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0049","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2133.1984.tb07320.x","article-title":"Centrifugal lipodystrophy","volume":"110","author":"Zachary","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000247120","article-title":"Lipodystrophia centrifugalis abdominalis infantilis occurring in the neck","volume":"188","author":"Higuchi","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0051","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.0736-8046.2004.21502.x","article-title":"Lipodystrophia centrifugalis abdominalis in Korea","volume":"21","author":"Chang","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0052","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-4632.2009.04090.x","article-title":"Lipodystrophia centrifugalis abdominalis infantilis manifesting as recurrent skin ulcerations","volume":"48","author":"Higashi","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0053","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000018377","article-title":"Lipodystrophia centrifugalis abdominalis infantilis with ulceration","volume":"200","author":"Aoki","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0054","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jdv.13031","article-title":"Lipodystrophia centrifugalis abdominalis infantilis accompanied by idiopathic encephalopathy","volume":"30","author":"Kaibuchi-Noda","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1346-8138.12322","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorders","volume":"41","author":"Park","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0056","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/emm.2014.105","article-title":"Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorders","volume":"47","author":"Cai","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0057","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V","article-title":"Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies","volume":"77","author":"Harabuchi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0058","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0059","first-page":"55","article-title":"Characteristics of nasal T\/NK-cell lymphoma among Brazilians","volume":"49","author":"Altemani","year":"2002","journal-title":"Neoplasma"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0060","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0061","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/00000478-200011000-00006","article-title":"Sinonasal NK\/T-cell lymphomas in the United States","volume":"24","author":"Gaal","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2019.106284","article-title":"Cutaneous extranodal natural killer (NK) \/T - cell lymphoma: a comprehensive clinical features and outcomes analysis of 71 cases","volume":"88","author":"Jiang","year":"2020","journal-title":"Leuk Res"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0063","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jaad.2013.12.023","article-title":"Cutaneous extranodal natural killer\/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site","volume":"70","author":"Lee","year":"2014","journal-title":"J Amer Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0064","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fped.2018.00289","article-title":"Epstein-Barr virus-positive T\/NK-cell lymphoproliferative diseases in Chinese mainland","volume":"6","author":"Ai","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fped.2019.00141","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: basic science and clinical progress","volume":"7","author":"Harabuchi","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0066","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2019.01.011","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder: clinicopathologic study of 41 cases","volume":"81","author":"Liu","year":"2019","journal-title":"J Amer Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0067","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0068","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2018893750","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites","volume":"133","author":"Cohen","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0069","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(84)80313-8","article-title":"Acquired, bilateral nevus of Ota-like macules","volume":"10","author":"Hori","year":"1984","journal-title":"J Amer Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaad.2008.10.054","article-title":"Acquired bilateral nevus of Ota-like macules (Hori nevus): etiologic and therapeutic considerations","volume":"61","author":"Park","year":"2009","journal-title":"J Amer Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0071","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.1987.tb07485.x","article-title":"Naevus fusco-caeruleus zygomaticus","volume":"117","author":"Sun","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0072","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/jid.2010.283","article-title":"A population-based study of acquired bilateral nevus-of-Ota-like macules in Shanghai, China","volume":"131","author":"Wang","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0073","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1524-4725.2000.99305.x","article-title":"Treatment of Hori's nevus with the Q-switched Nd:YAG laser","volume":"26","author":"Polnikorn","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0074","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2133.2005.06689.x","article-title":"Characteristics of Hori naevus: a prospective analysis","volume":"154","author":"Ee","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0749.1997.tb00481.x","article-title":"Clinical, pathological, and etiologic aspects of acquired dermal melanocytosis","volume":"10","author":"Mizoguchi","year":"1997","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0076","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3346\/jkms.2004.19.4.616","article-title":"Acquired, bilateral nevus of Ota-like macules (ABNOM) associated with Ota's nevus: case report","volume":"19","author":"Park","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0077","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/1346-8138.13193","article-title":"Induction of melasma by 1064-nm Q-switched neodymium:yttrium-aluminum-garnet laser therapy for acquired bilateral nevus of Ota-like macules (Hori nevus): a study on related factors in the Chinese population","volume":"43","author":"Wang","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0078","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3346\/jkms.2004.19.4.554","article-title":"Comparison of characteristics of acquired bilateral nevus of Ota-like macules and nevus of Ota according to therapeutic outcome","volume":"19","author":"Lee","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0079","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1524-4725.1999.99176.x","article-title":"Q-Switched ruby laser therapy of acquired bilateral nevus of Ota-like macules","volume":"25","author":"Kunachak","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0080","first-page":"937","article-title":"A retrospective study on the efficacy and complications of Q-switched alexandrite laser in the treatment of acquired bilateral nevus of Ota-like macules","volume":"27","author":"Lam","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0081","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5021\/ad.2009.21.3.255","article-title":"Q-switched Nd:YAG laser therapy of acquired bilateral nevus of Ota-like macules","volume":"21","author":"Lee","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0082","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2003.193","article-title":"Treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) using a combination of scanned carbon dioxide laser followed by Q-switched ruby laser","volume":"48","author":"Manuskiatti","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0083","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2017.12.053","article-title":"A split-face, single-blinded, randomized controlled comparison of alexandrite 755-nm picosecond laser versus alexandrite 755-nm nanosecond laser in the treatment of acquired bilateral nevus of Ota-like macules","volume":"79","author":"Yu","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0084","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/14764172.2013.793585","article-title":"Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd\/YAG laser","volume":"15","author":"Lee","year":"2013","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0085","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-4632.2008.04061.x","article-title":"Treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) using 1064-nm Q-switched Nd:YAG laser with low fluence","volume":"48","author":"Cho","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0086","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jamadermatol.2018.2671","article-title":"Picosecond laser treatment for acquired bilateral nevus of Ota-like macules","volume":"154","author":"Wong","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0087","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1524-4725.1996.tb00374.x","article-title":"Dermabrasian is an effective treatment for acquired bilateral nevus of Ota-like macules","volume":"22","author":"Kunachak","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0088","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u04abet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0089","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1002\/jcp.27576","article-title":"Beh\u04abet's disease: an immunogenetic perspective","volume":"234","author":"Salmaninejad","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0090","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3889\/oamjms.2018.393","article-title":"Beh\u04abet's disease\u2013case presentation and review literature","volume":"6","author":"Ferizi","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0091","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajo.2008.06.019","article-title":"Ocular inflammation in Beh\u04abet disease: incidence of ocular complications and of loss of visual acuity","volume":"146","author":"Kacmaz","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0092","first-page":"175","article-title":"Relationship between age at onset and clinical characteristics of Beh\u04abet's disease","volume":"27","author":"Ghembaza","year":"2018","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0093","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","article-title":"Demographic and clinical properties of juvenile\u2013onset Beh\u04abet's disease: a controlled multicenter study","volume":"58","author":"Karincaoglu","year":"2008","journal-title":"J Amer Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0094","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/abd1806-4841.20177359","article-title":"Beh\u04abet's disease: review with emphasis on dermatological aspects","volume":"92","author":"Scherrer","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0095","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close association of HLA-Bw51 with Beh\u04abet's disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0096","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Beh\u04abet's disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0097","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u04abet's disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0098","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u04abet's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0099","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Beh\u04abet's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11739-018-2000-1","article-title":"Triggering agents and microbiome as environmental factors on Beh\u04abet's syndrome","volume":"14","author":"Mumcu","year":"2019","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0101","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u04abet's disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0102","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u04abet's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0103","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u04abet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0104","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Beh\u04abet's syndrome\u2013a phase 2, placebo-controlled study","volume":"372","author":"Hatemi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13075-018-1793-7","article-title":"Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Beh\u04abet's disease: a large-scale, long-term postmarketing surveillance in Japan","volume":"21","author":"Ohno","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0106","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/09273948.2017.1421233","article-title":"Use of gevokizumab in patients with Beh\u04abet's disease uveitis: an international, randomized, double-masked, placebo-controlled study and open-label extension study","volume":"26","author":"Tugal-Tutkun","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0107","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/09273948.2018.1511810","article-title":"The presence of uveitis is associated with a sustained response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Beh\u04abet's disease","volume":"28","author":"Fabiani","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0108","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2018.09.002","article-title":"Efficacy of the anti-IL 17 secukinumab in refractory Beh\u04abet's syndrome: a preliminary study","volume":"97","author":"Di Scala","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2021.05.023_bib0109","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/09273948.2019.1587473","article-title":"The results of interferon-alpha treatment in Beh\u04abet uveitis","volume":"28","author":"Eser-Ozturk","year":"2020","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:20:18Z","timestamp":1760034018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0738081X21000882"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.05.023","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin diseases in Asian individuals that you do not want to miss: A selection of unique or relatively more common conditions in Asian populations","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}